📰 Dose Finding Study News
Dose Finding Study News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dose Finding Study. Real-time updates on events, politics, business and more.
February 8, 2024
Belhaven Biopharma Announces Groundbreaking Clinical Results for Nasdepi, ...
June 26, 2023
/PRNewswire/ -- Late breaking data focused on new drug therapy innovations to treat obesity were presented at the American Diabetes Associations® (ADA) 83rd...
June 24, 2023
Press Release­­­­­­­ No. 5 / 2023 Data shows nearly 19% weight loss in people with overweight or obesity in Boehringer...
June 24, 2023
Data from a phase 2 dose-finding trial from ADA 2023 suggests use of survodutide was associated with a mean body weight reduction of 14.9% at 46 weeks, with 67% of people using survodutide 4.8 mg losing 15% or more of their baseline body weight.
May 14, 2022
The shedding effect of Wuhan coronavirus (COVID-19) vaccines is affecting even the unvaccinated, causing serious health complications including blood clots so massive they're almost the size [...]
May 7, 2021
Glioblastoma Pipeline Analysis: 60+ Key Pipeline Therapies and 60+ Key Pharma Players are Looking Out in the Glioblastoma Pipeline Landscape iCrowd Newswire DelveInsights Glioblastoma Pipeline Insight report offers a detailed overview of the pipeline therapies that are in various clinical and preclinical stages of growth, as well as their launch and how the market is expected to change as a result across the Glioblastoma domain. For Glioblastoma emerging drugs, the Glioblastoma Pipeline Analysi...